429 related articles for article (PubMed ID: 9640411)
1. TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis.
Iitaka M; Momotani N; Hisaoka T; Noh JY; Ishikawa N; Ishii J; Katayama S; Ito K
Clin Endocrinol (Oxf); 1998 Apr; 48(4):445-53. PubMed ID: 9640411
[TBL] [Abstract][Full Text] [Related]
2. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.
McLachlan SM; Rapoport B
Thyroid; 2013 Jan; 23(1):14-24. PubMed ID: 23025526
[TBL] [Abstract][Full Text] [Related]
4. Induction of autoimmune hypothyroidism and subsequent hyperthyroidism by TSH receptor antibodies following subacute thyroiditis: a case report.
Iitaka M; Kakinuma S; Yamanaka K; Fujimaki S; Oosuga I; Wada S; Katayama S
Endocr J; 2001 Apr; 48(2):139-42. PubMed ID: 11456259
[TBL] [Abstract][Full Text] [Related]
5. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies.
McKenzie JM; Zakarija M
Thyroid; 1992; 2(2):155-9. PubMed ID: 1356056
[TBL] [Abstract][Full Text] [Related]
6. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
8. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
Balázs C
Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
[TBL] [Abstract][Full Text] [Related]
9. Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients.
Gonzalez-Aguilera B; Betea D; Lutteri L; Cavalier E; Geenen V; Beckers A; Valdes-Socin H
Arch Endocrinol Metab; 2018; 62(6):609-614. PubMed ID: 30624501
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
Ochi Y; Hamazu M; Kajita Y; Nagata A
Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
[TBL] [Abstract][Full Text] [Related]
12. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
13. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases.
Takasu N; Yamada T; Sato A; Nakagawa M; Komiya I; Nagasawa Y; Asawa T
Clin Endocrinol (Oxf); 1990 Dec; 33(6):687-98. PubMed ID: 1982861
[TBL] [Abstract][Full Text] [Related]
14. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.
Chen FQ; Okamura K; Sato K; Kuroda T; Mizokami T; Fujikawa M; Tsuji H; Okamura S; Fujishima M
Clin Endocrinol (Oxf); 1996 Aug; 45(2):207-14. PubMed ID: 8881454
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
Aizawa Y; Yoshida K; Kaise N; Kaise K; Fukazawa H; Kiso Y; Mori K; Sayama N; Kikuchi K; Abe K
Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
[TBL] [Abstract][Full Text] [Related]
16. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
[TBL] [Abstract][Full Text] [Related]
17. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
[TBL] [Abstract][Full Text] [Related]
18. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Maugendre D; Massart C
Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
[TBL] [Abstract][Full Text] [Related]
20. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
